We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
CryoPort
CYRX
$769M
| $655K | ﹤0.01% |
39,816
+1,273
| +3% | +$18.9K |
|
|
TLRD
2252
DELISTED
Tailored Brands, Inc.
TLRD
| $653K | ﹤0.01% |
157,788
+9,507
| +6% | +$44.7K |
|
2253
Miller Industries
MLR
$579M
| $652K | ﹤0.01% |
17,566
+27
| +0.2% | +$949 |
|
|
NVEE
2254
DELISTED
NV5 Global
NVEE
| $652K | ﹤0.01% |
51,680
+888
| +2% | +$12.9K |
|
2255
Geospace Technologies
GEOS
$95.1M
| $651K | ﹤0.01% |
38,809
+2,543
| +7% | +$38.6K |
|
2256
Snap
SNAP
$8.97B
| $651K | ﹤0.01% |
39,857
+570
| +1% | +$8.39K |
|
2257
Farmers National Banc Corp
FMNB
$941M
| $650K | ﹤0.01% |
39,811
-136
| -0.3% | -$2.07K |
|
2258
Byline Bancorp
BY
$1.79B
| $649K | ﹤0.01% |
33,176
+285
| +0.9% | +$5.21K |
|
2259
Palomar
PLMR
$3.55B
| $649K | ﹤0.01% |
+12,845
| New | +$602K |
|
2260
Virtu Financial
VIRT
$5.16B
| $649K | ﹤0.01% |
40,594
-694
| -2% | -$11.4K |
|
|
CNR
2261
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $646K | ﹤0.01% |
75,861
+2,206
| +3% | +$15.5K |
|
|
TRUE
2262
DELISTED
TrueCar
TRUE
| $645K | ﹤0.01% |
135,891
+909
| +0.7% | +$3.79K |
|
2263
Capital City Bank Group
CCBG
$895M
| $639K | ﹤0.01% |
20,966
+79
| +0.4% | +$2.28K |
|
|
TPIC
2264
DELISTED
TPI Composites
TPIC
| $637K | ﹤0.01% |
34,436
+457
| +1% | +$8.39K |
|
2265
BioCryst Pharmaceuticals
BCRX
$2.31B
| $635K | ﹤0.01% |
184,169
+9,107
| +5% | +$22.9K |
|
2266
Teekay
TK
$946M
| $635K | ﹤0.01% |
119,399
+513
| +0.4% | +$2.54K |
|
|
HCCI
2267
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $635K | ﹤0.01% |
20,235
+222
| +1% | +$6.35K |
|
|
DX
2268
Dynex Capital
DX
$3.19B
| $634K | ﹤0.01% |
37,399
+18
| +0% | +$291 |
|
|
PETQ
2269
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $633K | ﹤0.01% |
25,285
+1,678
| +7% | +$41.7K |
|
2270
Precigen
PGEN
$2.46B
| $628K | ﹤0.01% |
114,595
+2,274
| +2% | +$12.8K |
|
2271
West Bancorporation
WTBA
$482M
| $628K | ﹤0.01% |
24,498
-114
| -0.5% | -$2.71K |
|
|
ZEUS
2272
DELISTED
Olympic Steel
ZEUS
| $628K | ﹤0.01% |
35,070
+2,095
| +6% | +$33.3K |
|
2273
Krystal Biotech
KRYS
$9.64B
| $626K | ﹤0.01% |
11,308
+1,038
| +10% | +$50.9K |
|
2274
Titan International
TWI
$471M
| $626K | ﹤0.01% |
172,936
+5,792
| +3% | +$17.2K |
|
2275
Bar Harbor Bankshares
BHB
$679M
| $625K | ﹤0.01% |
24,599
-11
| -0% | -$280 |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.